Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation

Affiliations

¹ Baim Institute for Clinical Research, Boston, MA christopher.cannon@baiminstitute.org
² University of Birmingham, Birmingham, United Kingdom
³ Uppsala University, Uppsala, Sweden

Comment

Christopher P Cannon et al. N Engl J Med. 2018.

. 2018 Feb 1;378(5):485-486.

doi: 10.1056/NEJMc1715183.

¹ Baim Institute for Clinical Research, Boston, MA christopher.cannon@baiminstitute.org
² University of Birmingham, Birmingham, United Kingdom
³ Uppsala University, Uppsala, Sweden

No abstract available

Comment on

Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.
Wang X, Karnieg T. Wang X, et al. N Engl J Med. 2018 Feb 1;378(5):484. doi: 10.1056/NEJMc1715183. N Engl J Med. 2018. PMID: 29394037 No abstract available.
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.
Dekkers T, Lafeber M, Kramers C. Dekkers T, et al. N Engl J Med. 2018 Feb 1;378(5):484-5. doi: 10.1056/NEJMc1715183. N Engl J Med. 2018. PMID: 29394038 No abstract available.
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation.
Baduashvili A, Evans AT. Baduashvili A, et al. N Engl J Med. 2018 Feb 1;378(5):485. doi: 10.1056/NEJMc1715183. N Engl J Med. 2018. PMID: 29394039 No abstract available.